XKRX
28513K
Market cap706mUSD
Oct 08, Last price
25,200.00KRW
1D
-1.18%
1Q
21.45%
IPO
-14.58%
Name
SK Chemicals Co Ltd
Chart & performance
P/E
21.23
P/S
0.40
EPS
1,187.13
Div yield, %
5.34%
Shrs. gr., 5y
0.05%
Rev. gr., 5y
14.26%
Revenues
2.37t
+36.18%
Net income
44.65b
+405.11%
CFO
235.91b
P
Dividend
Aug 06, 2026400 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SK Chemicals Co. Ltd. engages in the manufacturing of chemicals, pharmaceuticals and other biomaterials. It operates through the Green Chemicals and Life Science business divisions. The Green Chemicals business division provides Copolyster, coating and adhesive materials, engineering plastic, Prepreg, Bio and 3D printing materials. The Life Science business division offers pharmaceuticals, vaccines and plasma derivatives. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.
Key people
Cheol Kim
Co-President, Co-Chief Executive Officer, Director · since 2019
Gwang Seok Lee
Assistant President
Jeong Yil Yang
Assistant President
Co-President, Co-Chief Executive Officer, Director · since 2023
Director · since 2025
Non-Executive Independent Director · since 2020
Seon Mi Choi
Non-Executive Independent Director · since 2024
Seong Hwan Moon
Non-Executive Independent Director · since 2020
Jeong Su Park
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2025
Headquarters & legal address
경기도 성남시 분당구 판교로 310 (삼평동)
Eco Lab
Seongnam-si, 41 13494
KR
Eco Lab
Seongnam-si, 41 13494
KR
Address
310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do
Eco Lab
Seongnam-si, 41 13494
KR
Eco Lab
Seongnam-si, 41 13494
KR
Other language
SK CHEMICALS CO.,LTD.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||